CDSCO Panel Tells Synokem to conduct phase 3 CT of antidiabetic FDC drug Dr. Divya Colin5 Feb 2023 6:00 PM ISTNew Delhi: Highlighting that there is no sufficient data, no unmet need & and FDC is not approved the drug internationally, the Subject Expert...
Include Albendazole associated diarrhoea in patient information leaflet: CDSCO Panel Susmita Roy4 Feb 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...
NPPA Fixes Retail Price Of 18 Formulations, Details Susmita Roy3 Feb 2023 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Insulin degludec may be considered during pregnancy: CDSCO Panel tells Novo Nordisk Dr. Divya Colin2 Feb 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to drug...
Alkem Gets CDSCO panel nod to manufacture, market antidiabetic FDC Drug Dr. Divya Colin1 Feb 2023 6:00 PM ISTNew Delhi: The drug major, Alkem Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Viral video shows COVID going to be "cash cow" for Pfizer, pharma giant issues response Farhat Nasim30 Jan 2023 7:21 PM ISTDelhi: Brewing controversy, a video featuring an allegedly Pfizer executive claiming about how his company was exploring purposely mutating COVID...
Sanofi Gets CDSCO panel nod to market Olipudase alfa for rare disease Dr. Divya Colin30 Jan 2023 6:00 PM ISTNew Delhi: Granting the local Phase III and phase IV clinical trial waiver in the country, the Subject Expert Committee (SEC) functional under the...
Cadila Gets CDSCO Panel Nod To Manufacture, Market Cholecalciferol aqueous injection Dr. Divya Colin29 Jan 2023 6:00 PM ISTNew Delhi: The Drug major, Cadila Pharmaceuticals has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Sanofi Gets CDSCO Panel Nod To Market Avalglucosidase Alfa Powder for Pompe Disease Dr. Divya Colin28 Jan 2023 6:00 PM ISTNew Delhi: Granting a local Phase III and Phase IV clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug...
Interim relief to Novartis: Delhi HC reinstates Entresto (Sacubitril-Valsartan) patent in India Farhat Nasim27 Jan 2023 6:26 PM ISTDelhi: In an interim relief to Swiss pharma major Novartis, the Delhi High Court has reinstated Entresto (sacubitril/valsartan) patent in India amid...
Roche gets CDCSO panel nod to market multiple sclerosis drug Ocrelizumab Dr. Divya Colin26 Jan 2023 6:00 PM ISTNew Delhi: Pharmaceutical major, Roche has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Control...
Eli Lilly gets CDCSO panel nod to import, market Galcanezumab Dr. Divya Colin25 Jan 2023 5:44 PM ISTNew Delhi: Drug major, Eli Lilly has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
